Insights into public preferences for pharmaceutical funding

about

A think aloud study comparing the validity and acceptability of discrete choice and best worst scaling methods.Public and decision maker stated preferences for pharmaceutical subsidy decisions: a pilot study.Australian Public Preferences for the Funding of New Health Technologies

P2860

Q35155987-EA685EF3-3CA6-4636-B494-D8769CCE908E Q39781561-94B5EA1E-CFF4-48B3-A15E-FCF24AF9405E Q57574202-6ECFA1EE-6CFA-4F17-9259-EE39478A4A82

P2860

Insights into public preferences for pharmaceutical funding

Item

http://www.wikidata.org/entity/Q57574361

description

article

@en

im September 2008 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2008

@uk

name

Insights into public preferences for pharmaceutical funding

@en

Insights into public preferences for pharmaceutical funding

@nl

type

Item

label

Insights into public preferences for pharmaceutical funding

@en

Insights into public preferences for pharmaceutical funding

@nl

prefLabel

Insights into public preferences for pharmaceutical funding

@en

Insights into public preferences for pharmaceutical funding

@nl

P1476

Insights into public preferences for pharmaceutical funding

@en

P2093

Jennifer A. Whitty

http://www.w3.org/2001/XMLSchema#string

Paul A. Scuffham

http://www.w3.org/2001/XMLSchema#string

Sharyn R. Rundle‐Thiele

http://www.w3.org/2001/XMLSchema#string

P2860

Using conjoint analysis to elicit preferences for health care

Measuring preferences for health care interventions using conjoint analysis: an application to HIV testing.

Resource allocation, social values and the QALY: a review of the debate and empirical evidence

The psychology of doing nothing: forms of decision avoidance result from reason and emotion.

QALY maximisation and people's preferences: a methodological review of the literature.

Is the value of a life or life-year saved context specific? Further evidence from a discrete choice experiment.

The use of QALY weights for QALY calculations: a review of industry submissions requesting listing on the Australian Pharmaceutical Benefits Scheme 2002-4.

Public views on priority setting for high cost medications in public hospitals in Australia.

Investigating the social value of health changes.

Community values and preferences in transplantation organ allocation decisions.

P304

216-234

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1108/17506120810903980

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2008-09-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

Insights into public preferences for pharmaceutical funding

about

P2860

P2860

Insights into public preferences for pharmaceutical funding

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577